Fully managed weight care with low-dose GLP-1s. One bundled price, medication included. No plan integration. Your clients get cost-controlled GLP-1 coverage. You get a benefit that earns its place in the portfolio.
Clinician, coach, medication, and app. All included. Pay only for engaged members.
If a member needs more medication, we absorb the cost. Our members average less than half the standard maximum dose. That's our bet to make.
No plan integration. No PBM involvement. No eligibility file at launch. Your client's HR team doesn't touch it.
The behavioral work is the intervention. Medication quiets the noise while members build skills that last. 78.5% taper or stop GLP-1s with no average weight regain.
See the researchSame dedicated coach. CBT and ACT-based. Nutrition, movement, sleep, stress, emotional eating.
Independently prescribed by a licensed clinician. Fewer side effects, less muscle loss, lower cost.
Planned from day one. Gradual, never rushed. 78.5% taper or stop successfully.
Continued coaching, accountability, and habit reinforcement after tapering.
Over 64 weeks. Consistent across BMI classes. Comparable to clinical trial results at a fraction of the medication.
~1.08 mg/week average. Less than half the 2.4 mg standard maximum.
No average weight regain at six months. This is Embla's own published research (Seier et al., Diabetes, Obesity and Metabolism, 2025).
Watch our co-founder walk through an actual employer report: engagement, weight loss, medication usage, tapering, and cost. This is what your clients receive and what you include in quarterly reviews.
A large U.S. health system launched Embla for its own employee population. No IT integration. No disruption to pharmacy benefits. Embla handled enrollment, onboarding, and ongoing management from day one.
GLP-1 access is a top-3 employee demand. A cost-controlled solution with published outcomes positions you as the advisor who brought the answer.
A fully managed carve-out with bundled pricing and peer-reviewed data is a different conversation than the same PBM-managed approach everyone else recommends.
No plan design changes. No PBM renegotiation. No carrier disruption. If it doesn't work, nothing was touched. If it does, you brought it.
Co-branded materials, client presentations, dedicated partner contact, and outcomes reporting for your reviews. We never go around you.
Sidhartha Sinha
Co-founder, Avant Health
The four questions every employer asks before saying yes. And the answers that close.
78.5% taper or stop with no average weight regain at six months. The program is designed from day one to make medication temporary.
Coverage alone means max dose, no behavioral support, no off-ramp. Embla bundles coaching with low-dose medication and a structured tapering protocol.
No. Standalone carve-out. No plan integration, no PBM, no eligibility file sync. Nothing changes except outcomes.
One flat PEPM regardless of dose. If a member needs more medication, Embla absorbs the cost. Exposure is fixed from day one.
One-pager, comparison table, client FAQ, and study summary. One PDF, one meeting.
The full guide to cost-controlled GLP-1 benefit design. Share it with clients directly.
Two pages. The largest real-world GLP-1 study published. The evidence behind the recommendation.
Talk to Paul about your book of business. He'll walk you through the model, the data, and what it looks like for your clients.
Or email [email protected] directly.
Medical services are provided by independently licensed clinicians, not by Embla Health US Inc. A licensed provider in your state evaluates eligibility for any treatment. Not everyone will qualify. Consultations are delivered via telehealth. Telehealth services may not be available in all states.